UK markets open in 3 hours 9 minutes

Artelo Biosciences, Inc. (ARTLW)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.01200.0000 (0.00%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/08/2021
31/08/2020
Cash flows from operating activities
Net income
-9,407
-9,289
-10,083
-7,437
-4,655
Depreciation & amortisation
-
-
-
-
0.5
Stock-based compensation
2,395
1,020
2,458
1,531
381
Change in working capital
74
703
-172
-242
-43
Accounts payable
273
273
23
-3
128
Other working capital
-6,934
-8,207
-8,008
-6,141
-4,347
Other non-cash items
-
-
-4
5
-
Net cash provided by operating activities
-6,934
-8,207
-8,008
-6,141
-4,347
Cash flows from investing activities
Investments in property, plant and equipment
-1,501
-
-
-
-
Purchases of investments
-14,453
-13,685
-13,224
-6,098
0
Sales/maturities of investments
17,192
17,192
16,182
2,659
0
Net cash used for investing activities
-1,501
3,507
2,958
-3,439
0
Cash flows from financing activities
Common stock issued
19,787
567
0
8,103
1,978
Common stock repurchased
-
-
-
-
-0.108
Other financing activities
-
-
-
-7
3
Net cash used provided by (used for) financing activities
25,795
567
0
14,112
1,981
Net change in cash
6,379
-4,073
-5,274
4,487
-2,282
Cash at beginning of period
5,783
6,888
12,162
2,142
4,424
Cash at end of period
12,227
2,815
6,888
6,629
2,142
Free cash flow
Operating cash flow
-6,934
-8,207
-8,008
-6,141
-4,347
Capital expenditure
-1,501
-
-
-
-
Free cash flow
-6,934
-8,207
-8,008
-6,141
-4,347